Planned intervention: On Wednesday April 3rd 05:30 UTC Zenodo will be unavailable for up to 2-10 minutes to perform a storage cluster upgrade.

There is a newer version of the record available.

Published July 9, 2020 | Version v11
Working paper Open

Ivermectin for Covid-19

  • 1. Politecnico di Torino

Description

Discussion of scholar papers published until end of June and beginning of July, 2020,  on Ivermectin, and of news that we can find about its use for Covid-19.  A list of clinical trials is also given. For what concerns scholar papers, we report among them a preprint posted on 10 June in MedRχiv,  which concludes that Ivermectin was associated with lower mortality during treatment of Covid-19.  From news, we consider in particular the case of Iquitos,  capital city of the Loreto Region in Peru, where, by May 25, Covid-19 cases and deaths had dropped notably. The formulation of ivermectin used in Peru is also discussed, in particular that of the oral solution disclosed by the Peruvian Government. A section about updating (8 July) is added to the discussion.  We report also the preprint posted on 8 July in MedRχiv, showing the result of a clinical trial. The preprint tells in the conclusions that add-on use of Ivermectin is giving better results when compared to controls, in particular a significant shorter hospital stay.

Notes

Before reading this work, please consider that I am not a physician. I do not suggest the use of ivermectin. I am not touting this drug. This analysis of publications and news about ivermectin is made in the framework of a wider investigation about information concerning drugs used for Covid-19.

Files

Ivermectin-11.pdf

Files (287.7 kB)

Name Size Download all
md5:ab94d511edf4128622d9fd7b3f2b85c0
287.7 kB Preview Download